While this is the very first time Mr. Trump has been implicated by New Delhi of making a discussion totally, it is not the very first time Mr. Trump has run into controversies by revealing details of conversations with the PM, consisting of with their most recent conversation on April 4 on hydroxychloroquine (HCQ), the drug Mr. Trump favours as a treatment for COVID-19
Also read: PM Modi not in ‘excellent state of mind’ over border row with China, says Trump
In its readout of the call of the very same day, the Ministry of External Affairs (MEA) made no mention of hydroxychloroquine, noting instead that the two leaders had spoken about the pandemic, its effect on the global economy, and even on the “significance of practices such as Yoga and Ayurveda” during these times.
Even as India reevaluated its decision, Mr. Trump spoke once again, this time appearing to threaten New Delhi if it did not release the drug to the U.S.
” If [PM Modi] does not permit it [HCQ] to come out, that would be OKAY, but of course there may be retaliation,” Mr. Trump stated, including insult to his earlier indiscretion.
